FRANCES BERNASKO: Open Payments
NPI 1386242329 · PALM BEACH GARDENS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 36 payments from 13 companies in 2025. Trend: 2023 $32 · 2024 $27 · 2025 $857
Food & beverage: $746Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $207 |
| Teva Pharmaceuticals USA, Inc. | 3 | $151 |
| Alkermes, Inc. | 5 | $104 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
Products named: VRAYLAR, LYBALVI, INGREZZA, REXULTI, CAPLYTA, Auvelity, COBENFY, FANAPT.
Industry payments across FL — which companies pay providers there.
